Bristol-Myers Squibb
BMY
#166
Rank
NZ$211.74 B
Marketcap
NZ$103.98
Share price
2.08%
Change (1 day)
0.12%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): NZ$5.12

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$4.95. In 2024 the company made an earnings per share (EPS) of NZ-$7.37 a decrease over its 2023 EPS that were of NZ$6.47.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$5.12-169.47%
2024NZ-$7.37-213.92%
2023NZ$6.4730.2%
2022NZ$4.97-6.04%
2021NZ$5.29-179.29%
2020NZ-$6.67-281.37%
2019NZ$3.68-27.21%
2018NZ$5.05
2016NZ$4.45175.26%
2015NZ$1.62-19.83%
2014NZ$2.02-22.44%
2013NZ$2.6034.48%
2012NZ$1.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.57 275.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.27 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.27-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.99-19.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.38 675.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$23.89 382.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.44-30.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$18.32 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.18 146.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$8.92 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK